Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Share-based Compensation (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Share-based Compensation for 15 consecutive years, with $3.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation rose 0.96% to $3.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.7 million, a 6.15% decrease, with the full-year FY2024 number at $14.6 million, changed 0.25% from a year prior.
  • Share-based Compensation was $3.6 million for Q3 2025 at Usana Health Sciences, down from $3.6 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.8 million in Q1 2022 to a low of $2.9 million in Q1 2025.
  • A 5-year average of $3.5 million and a median of $3.6 million in 2024 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: increased 19.31% in 2023, then decreased 21.5% in 2025.
  • Usana Health Sciences' Share-based Compensation stood at $3.7 million in 2021, then fell by 5.99% to $3.5 million in 2022, then grew by 3.61% to $3.6 million in 2023, then dropped by 0.82% to $3.6 million in 2024, then dropped by 1.02% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Share-based Compensation are $3.6 million (Q3 2025), $3.6 million (Q2 2025), and $2.9 million (Q1 2025).